Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests
Contact Dermatitis · 2023-11 · 89 (5) · 352-358
DOI: 10.1111/cod.14372 ↗At a glance
Journal article in Contact Dermatitis, published online on 2023-07-02. Written by Leonardo Bianchi and 10 co-authors. Institution: Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy. Major MEDLINE topics: Drug Hypersensitivity, Dermatitis, Allergic Contact, Iodine Compounds, Exanthema. Cited 15 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Background
Adverse drug reactions to iodinated contrast media (ICM) have risen due to their increasing use in x‐ray‐based imaging modalities. Delayed hypersensitivity reactions are mainly caused by nonionic monomeric compounds and represent an issue impacting the diagnostic–therapeutic pathways of cancer, cardiology and surgery patients.
Objectives
To prospectively evaluate the usefulness of skin tests in delayed hypersensitivity reactions to ICM and to evaluate the tolerability of iobitridol, a monomeric nonionic low osmolality compound, as a possible safe alternative.
Methods
Patients with delayed hypersensitivity reactions to ICM referred to us from 2020 to 2022 were prospectively enrolled in the study. All patients underwent patch test and, if negative, intradermal test with the culprit ICM and iobitridol as alternative.
Results
A total of 37 patients (females 24, 64.9%) were enrolled in the study. Iodixanol and iomeprol were the most frequently involved ICM (48.5% and 35.2%, respectively); 62.2% of patients presented maculopapular eruption, while 37.8% reported delayed urticaria‐like rash. Skin tests resulted positive to the culprit ICM in 19 patients (51.4%), 16 to patch test and 3 to intradermal test. Skin tests with iobitridol, tested as alternative, resulted positive in 3/19 patients (15.8%). All 16 patients with negative results to iobitridol were administered this ICM and tolerated it.
Conclusions
In at least half of patients, delayed‐type hypersensitivity was demonstrated by skin tests, particularly by patch test. This diagnostic approach resulted simple, cost‐effective and safe, not only to confirm the culprit ICM but also to identify iobitridol as feasible alternative.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Section of Dermatology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
- Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
- Section of Dermatology, Health Sciences Department, Magna Graecia University, Catanzaro, Italy.
ORCID profiles: Katharina Hansel, Maddalena Napolitano, Luca Stingeni
Cite
APA
Bianchi, L., Hansel, K., Biondi, F., Caroppo, E. S., Galeotti, T., Casciola, G., Tramontana, M., Marietti, R., Napolitano, M., Patruno, C., & Stingeni, L. (2023). Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests. Contact Dermatitis, 89(5), 352-358. https://doi.org/10.1111/cod.14372
Vancouver
Bianchi L, Hansel K, Biondi F, Caroppo ES, Galeotti T, Casciola G, et al. Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests. Contact Dermatitis. 2023;89(5):352-358. doi:10.1111/cod.14372
BibTeX
@article{Bianchi2023,
author = {Bianchi, Leonardo and Hansel, Katharina and Biondi, Filippo and Caroppo, Elena Sofia and Galeotti, Tommaso and Casciola, Gabriele and Tramontana, Marta and Marietti, Rossella and Napolitano, Maddalena and Patruno, Cataldo and Stingeni, Luca},
title = {Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests},
journal = {Contact Dermatitis},
year = {2023},
volume = {89},
number = {5},
pages = {352--358},
doi = {10.1111/cod.14372}
}
EUVIMED